Lv5
950 积分 2024-07-31 加入
Kinetic model of reversible addition fragmentation chain transfer polymerization of styrene in seeded emulsion
2天前
已完结
610O Preliminary results from a phase I, first-in-human study of DS-9606a, a claudin 6 (CLDN6)-directed antibody-drug conjugate (ADC), in patients (pts) with tumor types known to express CLDN6
12天前
已关闭
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial
16天前
已完结
Ab Initio Study of the Addition−Fragmentation Equilibrium in RAFT Polymerization: When Is Polymerization Retarded?
23天前
已完结
Ubiquitous Nature of Rate Retardation in Reversible Addition–Fragmentation Chain Transfer Polymerization
28天前
已完结
Review of Synthetic Routes and Crystalline Forms of the Oncology Drugs Capmatinib, Selpercatinib, and Pralsetinib
1个月前
已完结
Synthetic Approaches to the New Drugs Approved During 2020
1个月前
已完结
Recent advances and applications of peptide–agent conjugates for targeting tumor cells
1个月前
已完结
Unbalanced-Ion-Pair-Catalyzed Nucleophilic Fluorination Using Potassium Fluoride
1个月前
已完结
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
2个月前
已关闭
皖公网安备34019202002308
